Skip to main content
. 2022 Sep 27;65(19):13172–13197. doi: 10.1021/acs.jmedchem.2c00996

Figure 3.

Figure 3

SAR study plan for the PfGSK3/PfPK6 dual inhibitor IKK16. (GK = gatekeeper residue of the kinase).